NCT06490198 2024-07-08Phase 2 Study: OBI-833/OBI-821 Maintenance for Globo H+ Advanced Biliary Tract Cancer After Gemcitabine/CisplatinChang Gung Memorial HospitalPhase 1 Not yet recruiting30 enrolled